Pattern of venous thromboembolic diseases in a resources-limited setting in Cameroon by Abah, Joseph Pierre et al.




Pattern of venous thromboembolic diseases in a resources-limited setting in 
Cameroon 
 
Joseph Pierre Abah1,&, Alain Menanga2, Bertrand Hugo Mbatchou Ngahane3, Jacqueline Ze Minkande4, Manuel Ndo Akono5, 
Samuel Kingue2 
 
1Internal Medicine Unit, Military Hospital Bamenda, Bamenda, Cameroon, 2Department of Internal Medicine and Specialities, Faculty of Medicine 
and Biomedical Sciences, University of Yaounde 1, Yaounde, Cameroon,3Department of Clinical Sciences, Faculty of Medicine and Phamaceutical 
Sciences, University of Douala, Douala, Cameroon, 4Department of Anesthesiology and Reanimation, Faculty of Medicine and Biomedical Sciences, 
University of Yaounde 1, Yaounde, Cameroon, 5Internal medicine unit, Regional Hospital Bamenda, Bamenda, Cameroon 
 
&Corresponding author: Joseph Pierre Abah, Internal Medicine Unit, Military Hospital Bamenda, Bamenda, Cameroon 
 
Key words: Venous thromboembolism, deep vein thrombosis, pulmonary embolism, Cameroon 
 
Received: 10/05/2015 - Accepted: 14/10/2015 - Published: 26/04/2016 
 
Abstract  
Introduction: Admission for a medical illness is associated with an increased risk of venous thrombo-embolism; however reports addressing at 
this issue are rare in Cameroon. We sought to assess the pattern of thrombo-embolism among in-medical patients of a semi-urban hospital. 
Methods: We prospectively included 79 hospitalized medical patients of the Military Hospital of Bamenda (north-west region-Cameroon). From 
July 2010 and December 2013, we collected baseline demographic data, risk factors of venous thromboembolism, clinical presentation, diagnostic 
process and treatment. Results: In the 1445 patients admitted for medical illnesses, a total of 79 venous thrombo-embolic diseases were detected 
(55 deep vein thrombosis, 14 pulmonary embolism, 9 post-phlebitic syndrome and 1 cerulae alba dolens). The leading risk factors were prolonged 
immobilization (100%), age > 40 years (78.9%), obesity (43%), long distance travel (30.4%) and HIV-AIDS (21.5%). Thirty one (40.5%) had ≤ 2 
cumulative risk factors, and 8 (10.1%) more than 4. All the patients in the group had a significant risk of deep vein thrombosis: 5 (6.3%), 34 
(43%) and 40 (50.6%) with moderate, high and very high risk respectively. Increasing number of deep vein thrombosis was associated with 
increasing level of the risk and the clinical probability scores. Lower limb location of deep vein thrombosis was the most frequent with 75 (94.9%) 
cases. Almost all the patients received appropriate therapy with heparin and oral anticoagulant during their hospital stay. The mean length of 
hospital stay was 17.5 +/-15 (range 4- 62) days; disability and death occurred in 15 (19%) and 17 (21.5%) respectively. Conclusion: Venous 
thromboembolism is also a common concern in a semi-urban practice of our country. Long distance travel, one of the leading risk factors merits to 
be more specifically studied. 
 
 
Pan African Medical Journal. 2016; 23:236 doi:10.11604/pamj.2016.23.236.7034 
This article is available online at: http://www.panafrican-med-journal.com/content/article/23/236/full/ 
 
© Joseph Pierre Abah et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original 
work is properly cited. 
 
Pan African Medical Journal – ISSN: 1937- 8688   (www.panafrican-med-journal.com) 








Page number not for citation purposes 2 
Introduction 
 
As reported in Western countries, venous thromboembolism (VTE) is 
now a well-established major concern among in-patients in sub-
saharian Africa [1-3]. Venous thromboembolism includes deep vein 
thrombosis (DVT) and its acute complication, pulmonary embolism. 
Although their cause is still unknown, the Virchow triad of venous 
stasis, hypercoagulability and endothelial injury, permits to define 
risk factors of these affections. Studies have established that VTE is 
a multifaceted disease [4]. In both surgical and medical wards, 
these risk factors accumulate, increasing the incidence of VTE, and 
worsening the prognosis of in-patients (morbidity, disability, 
impaired recovery and mortality). Unfortunately, because of missed 
or delayed diagnosis, the true incidence of VTE remains unknown, 
especially in medical wards [5, 6]. Consequently, it is still under-
estimated among medically-ill patients. It is estimated that only 
16% to 33% of such patients receive thromboprophylaxis as 
compared to up to 90% of at-risk surgical patients [7-9]. In 
Cameroon, there is scarcity of studies, all conducted in reference 
hospitals in an urban area, that have assessed risk factors (mainly 
clinical and environmental), prevention and treatment of VTE [1,10]. 
Hence, we sought to study, in a semi-urban and rural hospital 
setting, the pattern of VTE in terms of risk factors, clinical 





Design and setting 
  
This cross-sectional study was carried out in Military Hospital of 
Bamenda from the 1st July 2010 to the 31st December 2013. 
Physicians of the so-called hospital were among the most aware of 
the VTE risk in this semi-urban region of Cameroon. The estimated 
1.500 000 inhabitants of the Region was made of public servants, 
students, farmers, livestock farmers and traders. Daily, they tackled 
uncomfortable trips in overloaded old cars, going round bad roads 
for long hours to join the nearer town or village. In the other hand, 
health facilities were both under-equipped and of very limited 
access. Hence, efficacious involvement for prevention, diagnosis and 






We included consecutive adults aged 18 years or above. The 
patients were ill with a diagnosis of DVT and/or PE at or during their 
hospitalization. The ethics committee of the medical region 
approved the study protocol, and an informed consent was obtained 




Data were collected using a pre-designed questionnaire. They 
consisted of demographic characteristics (age, gender), risk factors 
of VTE, diagnostic process (clinical presentation of DVT and/or PE, 
diagnostic testing), treatment outline and prognosis components 
(days of hospital stay, disability, death). Inclusion of each patient 
started by listing out the clinical and environmental risks factors of 
VTE (genetics could not be assessed). Each risk factor was ranked 
according to a point scale proposed by a consensus statement in 
2001 [11,12]: Risk factors weighting 5 points (stroke < 1 month), 3 
points (age of 75 years or more, prior VTE); 2 points (age 60 to 74 
years, cancer, immobilization with a plaster, patient confined to bed 
for 72 hours or more, central venous access); and the 1 point (age 
40 to 60, obesity, bed rest, varicosise, acute heart failure, sepsis, 
serious lung disease, acute myocardial infarction, inflammatory 
bowel disease, hormone-replacement therapy, oral contraceptive). A 
cumulative score of 0-1 defined a low risk, 2 a moderate risk, 3-4 a 
high risk and 5 or more a highest risk of VTE. Even though it is not 
included in this scaling risk score, we also considered long distance 
travel, defined as a trip of 4 hours or more, by car, plane, train or 
ship. Thereafter, a general clinical exam was conducted, taking in 
symptoms and detailed examination of the lower limbs, the 
respiratory and cardiovascular systems to search for signs of DVT 
and PE. The clinically suspicious DVT and PE were scaled by well-
known probability scores [13-15]. For DVT, the Wells' score of DVT: 
low probability for a score of 0 or less; intermediate probability for a 
score of 1 to 2; and the high probability for 3 and above. For PE, 
the Wells' score for PE (low probability between 0 to 1; intermediate 
probability between 2 to 6; and high probability for a score of 7 and 
more); and the reviewed Geneva score (low probability 0 to 3; 
intermediate probability 4 to 10; and high probability for a score of 
11 and more). After these clinical estimations of the probability of 
VTE, venous ultrasound and computerized tomographic pulmonary 
angiography (CTPA) were performed by consultant radiologists. 
Venous Doppler was performed using a 7.5-10 MHz linear 
transducer of sonographic machine (Sonoscape S2/S2BW; GE logiq 
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400). For a confirmed DVT, a progressive compression of veins in 1 
to 2 cm increments from the thigh to the calf showed a lack of vein 
compressibility with the transducer held transversely; the 
visualization of the clot with color flow and pulsed Doppler wave 
terminated the diagnosis. Computerized tomographic pulmonary 
angiography was performed to diagnose PE. After intravenous 
injection of Meglumine Loxilamalate, anatomic views were obtained. 
Testing was positive for PE when an intravascular filling defect was 
present on one or more views of pulmonary artery branches. 
Patients were definitely included when DVT or PE testing were 
positive. Treatment included mechanical (stocking) and 
pharmacological elements (low-molecular-weight heparin, 
unfractionated heparin, acenocoumarol, warfarin). Number of 
disable patients (with large chronic ulcers secondary to post-




Data analysis used the Statistical Package for Social Sciences 
version 13.1 (SPSS Inc Chicago, IL). Continuous data, presented as 
means and standard deviation were compared using the t-test. 
Categorical data were presented as frequencies and proportions, 






Of the overall 1445 patients admitted for a medical-illness during 
the 3 years of recruitment, 143 (9.9%) had a suspicion of VTE. 
Thirty seven of them (25.9%) had not run for radiologic testing (33 
for venous Doppler and 5 for CTPA); and 27 (18.9%) presented 
negative testing (23 negative for DVT and 7 for PE). Finally, 79 
patients with a positive testing for VTE were included. Of these 41 
(51.9%) were men. The mean age of the participants was 56.4 ± 
15.8 years. The mean age of men (59.1 years) was not statistically 
different of that of women (53.5 years) (p = 0.11). Table 
1 summarized the primary causes of admission. They were not 
exclusive. DVT and PE ordered admission in 18 (22.8%) and 4 
(5.1%) cases respectively, high blood pressure 30 (38%), acute 
heart failure 18 (22.8%) and Stroke 8 (10.1%). Table 2 and Table 
3 detailed demographic characteristics, risk factors and clinical 
presentation in the group. The leading risk factors were 
immobilization (100%), obesity (34 (43%)), long travel (24 
(30.4%)), and HIV infection and its opportunistic diseases (17 
(21.5%)). Of the 79 patients, 31 (40.5%) had ≤ 2 risk factors, 40 
(50.6%) 3 to 4 risks factors and 8 (10.1%) ≥ 5. No patient was at 
low risk. The risk was moderate on 5 (6.3%) patients and high to 
highest in 74 (97.7%). Figure 1 shows a distribution of VTE (DVT 
and PE) among the clinical ranking of DVT risk (A), and probability 
scores (B, C, D), preceding the radiologic testing. Regarding the 
level of DVT risk, no patient was at low risk, being it among those 
suffering of DVT or PE; and the increasing level of the risk was 
associated with an increasing number of both DVT and PE 
(moderate, high and very high level of risk corresponded 
respectively to 4, 24 and 27 cases of DVT, and 1-6-8 cases of PE). 
Identical observation could be made with the Wells' score for DVT 
(12, 22 and 31 DVT and 1, 5, 8 PE for the low, intermediate and 
high probability respectively). In the other hand, all the patients 
with PE had intermediate-to-high clinical probability of PE; no 
patient suffering of PE had a low probability score for PE. The 
overall diagnostic result showed 55 (69.6%) DVT, 14 (17.7%) PE, 9 
(11.3) post-phlebitic diseases, and 1 (1.3%) phlegmasia cerulea 
dolens. DVT had lower limb location in 75 (94.9%) patients, strictly 
proximal in 42 (53.2%) and proximal + distal in 12 (15.2%). Other 
location (cerebral, upper limb) represented 4 (5.1%) of all the cases 
of DVT. The recommended tools in the treatment of VTE were 
implemented for almost all the patients. Unfractionated heparin was 
never used. Mechanical consisted mainly in stocking and early 
ambulation. The mean length of hospital stay was 17.5 ± 15(4-62) 
days; disability and death occurred in 15 (19%) and 17 (21.5%) 
respectively. The mortality rate was significant higher among 






Being a prospective study that enrolled consecutive patients 
admitted for medical illness, our population closely reflects the 
pattern of illness that a physician specialized in internal medicine 
may encounter in a typical semi-urban care unit. Thus as expected, 
our population consisted mostly of severely ill patients, and this may 
explain why many presented a wide spectrum of critical risk factors 
for VTE such as strokes, prior VTE and cancer; and these risk 
factors were commonly cumulative. Both high-to-highest risk of VTE 
cumulation of risk factors was associated with high frequency of 
VTE. Almost this same sharing in risk factors was found in some 
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other works in urban areas of sub-saharian Africa (SSA) 
[10, 16, 17]. Studies have well demonstrated an increased risk of 
VTE in the presence of multiple risk factors [11]. Even when there is 
an adequate thromboprophylaxis, incidence of VTE is still between 
10 to 25% when risk factors cumulate [18, 19]. Implication of HIV-
AIDS in the occurrence of VTE was significant. This has been well 
demonstrated in many studies [20, 21], and is just an increasing 
concern. Such a finding illustrates the burden of this infection and 
its opportunistic diseases in SSA. Long travel was among the most 
common risk factors in our study. Even though earlier studies 
demonstrated that it was a minor risk factor [22-24], we may 
mention it considering the travelling conditions in rural and semi-
urban areas of SSA. As reported by others, we found that obesity 
and age of ≥ 40 years were commonly present on patient with VTE 
[25, 26]. Another re-statement was that scaling suspicious patient 
with a pretest probability score for DVT or PE, by increasing the 
predictive value of venous Doppler and CTPA, simplifies and 
improve the diagnostic process. This statement has clearly been 
made by Wells et al, and many other studies [13-15]. This 
conclusion is of great importance in SSA where diagnostic testing, 
when available, needs to be more accurately performed. 
Furthermore, even if there are no recommendations on how to 
manage such cases, when pretest probability is high, it may be very 
useful to initiate an effective treatment in our area where tests are 
usually delayed or not performed. As malpractices in the diagnostic 
process, we noticed that all the patients with a suspicion of VTE 
could not undergo testing, some because of its cost and others 
when the scarce diagnostic tools had a breakdown, or the unique 
radiologist was absent. This situation most likely led to under-
diagnosed VTE. Elsewhere, it was the D-dimers testing that could 
not be performed when indicated. Concordant prospective studies 
have clearly shown that D-dimers testing combined with pretest 
probability allows rapid and safe exclusion of VTE, preventing costly 
serial radiologic testing when the testing was negative [27, 28]. 
Difficulties in the proper implementation of the diagnostic process of 
VTE are common in SSA and have been stated in some studies 
[10, 29]. This highlights the under-equipment and low-access to 
health facilities in our area. Another reason is an insufficient number 
of specialists trained for management of VTE in medical wards. This 
emphasizes the need to increase the number of internists and 
radiologists in semi-urban areas of our country. Almost all the 
positive cases of VTE received appropriate therapy with low-weight 
molecular heparin, oral anticoagulant and non- pharmacological 
treatment. Mortality and disability are significant ensues among our 
population. It was cluster of some comorbidities and the worse 
evolution of VTE as such [30, 31]. Our study has several limitations. 
It showed concern only in the in-hospital treatment. The ambulatory 
compliance and follow-up is another important point that was not 
assessed here. Elsewhere it was conducted in only one hospital, 
even though there was exercising one of the scarce health team 
aware of the VTE risk in the area. This is reducing the global 





Our study demonstrates that VTE remains a common condition in 
medical wards of a semi-urban hospital. Long distance travel is 
among the leading risk factors, and thus merits to be furthermore 
assessed. These results indicate a quick on the implementation of 
guidelines addressing the practice on these affections. 
 
What is known about this topic 
 Venous thromboembolism is a major health concern in 
sub-Saharan Africa, sharing the same trend as in western 
countries; 
 Management of venous thromboembolism faces problems 
related to under-equipped hospitals and availability of 
trained personnel; 
 Data on VTE are scarce in semi-urban and rural area. 
 
What this study adds 
 Increase the number of available data on venous 
thromboembolism in a region where studies on the topic 
are scarce; 
 Describe a trend of management of the disease in a semi-
urban area where under-equipment and availability of 
trained personnel are more underlined; 
 Immobilization, obesity and long distance travel are the 
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Table 1: Primary causes of admission 
Variables Number Percent (%) 
Deep vein thrombosis 18 22.8 
Pulmonary embolism 4 5.1 
HIV and opportunistic infections 9 11.4 
Other infectious conditions 5 6.3 
Malignancy 3 3.8 
Acute heart failure 18 22.8 
High blood pressure 30 38 
Acute diabetic decompensation 1 1.3 
Decompensation of Chronic pulmonary 
disease 
7 8.9 
Acute uremic syndrome 5 6.3 
Stroke 8 10.1 
Rheumatic disease 2 2.5 
Coma 2 2.5 
Hepatic disease 6 7.6 
Psychiatric disease 3 3.8 
Others 4 5.1 
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Table 2: Demographic profile and risk factors of DVT (N=79) 
Variables Number Percent (%) 
Demographics     
Number of admissions 1445   
Suspicious cases of VTE 143   
Number of tested patients 106   
Confirmed VTE cases 79 100.0 
Age, year  [mean±SD (range)] 56.4±15.8 (23 - 90)   
Weight, kilogram 
 [mean ± SD (range)] 
28.0±6.9 (16 – 45.7)   
Gender (males) 41 51.9 
Duration of admission, days 
[mean ± SD (range)] 
17.5±15 (4 – 62)   
Handicap 15 19.0 
Death 17 21.5 
Risk factors     
Past history of venous 
thromboembolism 
6 7.6 
Varicosis 9 11.4 
Age over 40 years 56 78.9 
Obesity 34 43.0 
Malignancy 6 7.6 
Cancer chemotherapy 2 2.5 
Smoking 3 3.8 
Stroke 8 10.1 
Prolonged immobilization 79 100.0 
Central venous access 2 2.5 
HIV and opportunistic diseases 17 21.5 
Long distance travel 24 30.4 
Oral contraceptive 2 2.5 
Anemia 7 8.9 
Cumulative risk factors     
≤2 risk factors 31 40.5 
]2 – 4] risk factors 40 50.6 
>4 risk factors 8 10.1 
Venous thromboembolism 
risk 
    
Low risk 0 0 
Moderate risk 5 6.3 
High risk 34 43 
Very high risk 40 50.6 
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Table 3: Clinical and diagnostic presentation of patients, and treatment (N=79) 
Clinics Number Percent (%) 
Lower limb swelling 68 86.1 
Spontaneous lower limb pains 58 73.4 
Lower limb warmth 65 82.3 
Tenderness 42 53.2 
Red or discolored skin 42 53.2 
Dilation of superficial veins 9 11.4 
Ulcer 15 19 
Fever 33 41.8 
Tachycardia 48 60.5 
Chest pains 22 27.8 
Sudden cough 19 24.0 
Shortness of breath, dyspnea 15 19 
Hemoptysis 7 8.9 
Hypotension, sweeting, cyanosis 7 8.9 
Right heart failure 11 13.9 
Lower limb ischemia 4 5.1 
Deep vein thrombosis Well’s Score:     
Low probability 13 16.4 
Intermediary probability 27 34.2 
High probability 39 49.4 
Pulmonary Well’s Score:     
Low probability 40 50.6 
Intermediary probability 11 13.9 
High probability 18 22.8 
Pulmonary Geneva Score:     
Low probability 43 54.4 
Intermediary probability 13 16.4 
High probability 13 16.4 
Positive tests     
Deep vein thrombosis 55 69.6 
Pulmonary embolism 14 17.7 
Post-phlebitic disease 9 11.3 
Phlegmasia dolens 1 1.3 
Localization of DVT     
Lower limb proximal 42 53.2 
Lower limb distal 21 26.6 
Lower limb proximal + Distal 12 15.2 
Other localization 4 5.1 
Treatment     
Non-fractioned heparin 0 0 
Low-molecular-weight heparin 75 94.9 
Antivitamine K 67 84.8 








Figure 1: Distribution of VTE (DVT and PE) in the clinical steps used in the diagnostic 
process of VTE: level of the DVT risk (A), well’s score for DVT (B), well’s score for PE (C), 
and Geneva score (D); each criteria is ranked low, moderate, high and very high (A), and 
low, intermediary and high (B,C,D); data is expressed as mean number of DVT and PE 
among each rank; the 9 cases of post-phlebitic diseases and 1 case cerulea alba dolens 
were taken into account as DVT to built this figure 
 
